Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial.
Sean M BagshawAry Serpa NetoOrla SmithMatthew WeirHaibo QiuBin DuAmanda Y WangMartin GallagherRinaldo BellomoRon Waldnull nullPublished in: Intensive care medicine (2022)
In this secondary analysis of the STARRT-AKI trial, an accelerated strategy of RRT initiation conferred a higher risk of 90-day RRT dependence among patients with pre-existing CKD; however, no effect was observed in the absence of CKD.